Business Description
Medicover AB
ISIN : SE0009778848
Share Class Description:
LTS:0RPS: Class BCompare
Compare
Traded in other countries / regions
MCOV B.Sweden5M0B.Germany0RPS.UKMCVEY.USA IPO Date
2017-05-25Description
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.24 | |||||
| Debt-to-Equity | 2.29 | |||||
| Debt-to-EBITDA | 3.96 | |||||
| Interest Coverage | 1.13 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.2 | |||||
| 3-Year EBITDA Growth Rate | 20.9 | |||||
| 3-Year EPS without NRI Growth Rate | -25 | |||||
| 3-Year FCF Growth Rate | 6 | |||||
| 3-Year Book Growth Rate | 6.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 103.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 16.15 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.68 | |||||
| 9-Day RSI | 51.93 | |||||
| 14-Day RSI | 48.2 | |||||
| 6-1 Month Momentum % | -1.89 | |||||
| 12-1 Month Momentum % | 29.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | |||||
| Quick Ratio | 0.63 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 14.3 | |||||
| Days Sales Outstanding | 44.53 | |||||
| Days Payable | 43.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.79 | |||||
| Dividend Payout Ratio | 0.92 | |||||
| Forward Dividend Yield % | 0.79 | |||||
| 5-Year Yield-on-Cost % | 0.79 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -4.44 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.71 | |||||
| Operating Margin % | 3.29 | |||||
| Net Margin % | 0.98 | |||||
| FCF Margin % | 6.15 | |||||
| ROE % | 3.93 | |||||
| ROA % | 0.98 | |||||
| ROIC % | 2.7 | |||||
| ROC (Joel Greenblatt) % | 8.36 | |||||
| ROCE % | 5.29 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 123.94 | |||||
| Forward PE Ratio | 33.24 | |||||
| PE Ratio without NRI | 123.94 | |||||
| Shiller PE Ratio | 85.16 | |||||
| Price-to-Owner-Earnings | 17.09 | |||||
| PEG Ratio | 5.82 | |||||
| PS Ratio | 1.21 | |||||
| PB Ratio | 4.82 | |||||
| Price-to-Free-Cash-Flow | 19.74 | |||||
| Price-to-Operating-Cash-Flow | 10.06 | |||||
| EV-to-EBIT | 43.9 | |||||
| EV-to-EBITDA | 11.81 | |||||
| EV-to-Revenue | 1.72 | |||||
| EV-to-FCF | 27.96 | |||||
| Price-to-Projected-FCF | 1.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.3 | |||||
| Earnings Yield (Greenblatt) % | 2.28 | |||||
| FCF Yield % | 5.25 | |||||
| Forward Rate of Return (Yacktman) % | 22.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicover AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 22,554.003 | ||
| EPS (TTM) (kr) | 1.47 | ||
| Beta | 2.48 | ||
| Volatility % | 37.64 | ||
| 14-Day RSI | 48.2 | ||
| 14-Day ATR (kr) | 3.421946 | ||
| 20-Day SMA (kr) | 177.382858 | ||
| 12-1 Month Momentum % | 29.95 | ||
| 52-Week Range (kr) | 129.4 - 206.5 | ||
| Shares Outstanding (Mil) | 150.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicover AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicover AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicover AB Frequently Asked Questions
What is Medicover AB(LTS:0RPS)'s stock price today?
The current price of LTS:0RPS is kr178.20. The 52 week high of LTS:0RPS is kr206.50 and 52 week low is kr129.40.
When is next earnings date of Medicover AB(LTS:0RPS)?
The next earnings date of Medicover AB(LTS:0RPS) is 2025-02-07 Est..
Does Medicover AB(LTS:0RPS) pay dividends? If so, how much?
The Dividend Yield %  of Medicover AB(LTS:0RPS) is 0.79% (As of Today), Highest Dividend Payout Ratio of Medicover AB(LTS:0RPS) was 1.58. The lowest was 0.1. And the median was 1.19. The  Forward Dividend Yield % of Medicover AB(LTS:0RPS) is 0.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers